Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (2656)	12/9/2010 11:58:34 AM
From: D.Lu	Respond to of 3027

"pompous"? I didn't know Dew was from Pompeii.

To: mopgcw who wrote (2656)	12/9/2010 1:09:51 PM
From: tom pope	Read Replies (1) \| Respond to of 3027

Pompous? I've delegated to Dew my papal infallibility, so his attitude is understandable.

To: mopgcw who wrote (2656)	12/9/2010 1:25:15 PM
From: DewDiligence_on_SI	Read Replies (1) \| Respond to of 3027

Your attempt at consensus building is puerile, George. We’re all adults here and we do not need to have criticism sugarcoated when an assertion is erroneous. Peter and Tuck were plainly wrong in saying that M118 will take precedence over the FoB programs, and Rick Shea (MNTA’s CFO) confirmed this with his comments in BioWorld Today that I linked to in my previous post. This is not a matter of opinion anymore. I’ve been double-posting about MNTA on iHub and SI as a service to readers here who do not have accounts on iHub and do not like to navigate through all of the muck there. I will not be doing that anymore.